Can You Stop Wegovy After 1 Month — and What Happens If You Do?

What is actually happening in your body after just one month?

A question our prescribers hear most weeks is some version of: "I've only been on it a month, is it even worth stopping now?" It is worth understanding what one month actually means in the treatment timeline.

Wegovy's starting dose of 0.25mg is not a therapeutic amount. It is the body's introduction period, your system gets used to slowed gastric emptying, reduced appetite signalling and the early GI effects that come with it. Most people spend their first four weeks here, then move to 0.5mg, then 1.0mg, and so on in roughly four-week steps, working towards the 2.4mg maintenance dose. Some people move to the higher 2.4mg or the newer 7.2mg maintenance doses over many months.

If you stop at one month, you have likely never reached a dose where semaglutide was doing its full job, and our page on what Wegovy does after one month explains in detail what is and is not happening at that early stage. The full Wegovy treatment overview covers the titration schedule in more detail.

Physically, stopping at this stage tends to be straightforward. Semaglutide has a half-life of roughly one week, so it clears your body gradually over several weeks after your last injection. There are no known withdrawal effects. What most people notice is that appetite returns (sometimes quickly, sometimes over a couple of weeks) because the appetite-suppressing signal from the medicine fades.

Does weight come back when you stop Wegovy this early?

The honest answer: for most people, yes, though the picture is more nuanced than headlines suggest.

The STEP 1 clinical trial, published in the New England Journal of Medicine, followed participants who stopped semaglutide 2.4mg after 68 weeks of treatment. Within one year of stopping, about two-thirds of the weight lost during the trial had returned on average. That is after over a year at or near a maintenance dose. Stop after one month at 0.25mg and the effect on appetite suppression (let alone weight) has been minimal, so there is less acute "rebound" to speak of. But the conditions that made weight management difficult in the first place have not changed.

This is not about willpower. Obesity medicine increasingly recognises that appetite regulation is hormonal and metabolic, not a character trait. Semaglutide reduces hunger signals for as long as it is in your system. When it leaves, those signals return to baseline. That is why clinical guidance (including NICE's appraisal of semaglutide for weight management (TA875)) frames weight management medicines as longer-term tools, not short courses.

If you stopped at one month because of side effects, cost, a change in circumstances or simply because it did not feel right, that is a legitimate decision. It is worth exploring those reasons with a prescriber rather than just stopping quietly, because some of them are solvable.

Is stopping after one month different from stopping after three or six months?

Yes, in meaningful ways. Duration at a therapeutic dose is the relevant variable. One month in, most people have not yet reached a dose that has materially shifted their weight or their appetite long-term. Stopping at that point is closer to not starting than it is to stopping mid-treatment.

After three months, some people have reached or are approaching the 1.0mg dose and may have lost several percent of their body weight. The decision to stop there involves a different conversation, about progress made, dose trajectory, and what a pause means physiologically. Our page on stopping Wegovy after three months covers that specific scenario in detail.

After six months at or near maintenance, the calculation shifts again. The body has adapted, lifestyle changes may be embedded, and the risks of regain are more significant and well-documented. We have a separate page on stopping Wegovy after six months if that is where you are.

The short version: earlier in treatment, stopping is medically lower-risk but also means the treatment has had less chance to work. Later in treatment, stopping is a more consequential clinical decision. In either case, it deserves a proper conversation. You can review broader treatment options (including what comes next if Wegovy is not the right fit) on our weight-loss treatments page.

What should you actually do if you want to stop?

Tell your prescriber. That sounds obvious, but a significant number of people simply stop taking the injections and say nothing, which means no one reviews whether the reason is fixable, whether a lower dose might suit better, or whether a planned break with a restart date makes more sense than an open-ended pause.

Semaglutide does not need to be tapered the way some medicines do. You can stop between doses without a physical risk from the stopping itself. But "medically safe to stop" and "the best decision for your situation" are not the same thing. A prescriber can help you distinguish between the two.

If the issue is the injections themselves, it is worth knowing that oral semaglutide (an alternative form of the same medicine) was approved in the UK in June 2026 for weight management, giving people who find injections difficult another route. If the issue is cost, our page on how Wegovy is accessed and priced in the UK explains what a legitimate private prescription should include. Speak to our prescribers if you are unsure which direction makes sense for you.